The effect of Astragaloside IV on immune function of regulatory T cell mediated by high mobility group box 1 protein in vitro

Fitoterapia

Volumn 83, Issue 8, 2012, Pages 1514-1522

  Huang, Li Feng ^a,b,c   Yao, Yong Ming ^b   Li, Jin Feng ^c   Zhang, Shu Wen ^a   Li, Wen Xiong ^c   Dong, Ning ^b   Yu, Yan ^b   Sheng, Zhi Yong ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Astragaloside IV; High mobility group box 1 protein; Regulatory T cell; Sepsis; T lymphocyte

Indexed keywords

ASTRAGALOSIDE IV; HIGH MOBILITY GROUP B1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL CULTURE; CELL ISOLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REGULATORY T LYMPHOCYTE; SPLEEN;

ANIMALS; ANTIGENS, CD4; CELL PROLIFERATION; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HMGB1 PROTEIN; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MICE; MOLECULAR STRUCTURE; RNA, MESSENGER; SAPONINS; SPLEEN; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TRITERPENES;

ASTRAGALUS MONGHOLICUS; MUS;

EID: 84870798108     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2012.08.019     Document Type: Article

References (45)

1. C.S. Hsieh, H.M. Lee, and C.W. Lio Selection of regulatory T cells in the thymus Nat Rev Immunol 12 2012 157 167
2. A.N. McMurchy, and M.K. Levings Suppression assays with human T regulatory cells: a technical guide Eur J Immunol 42 2012 27 34
3. R.M. Maizels, and K.A. Smith Regulatory T cells in infection Adv Immunol 112 2011 73 136
4. Y.M. Yao, and L.F. Huang The potential role of regulatory T cells in postburn sepsis Zhonghua Shao Shang Za Zhi 27 2011 81 83
5. C.G. Vinuesa, and J.G. Cyster How T cells earn the follicular rite of passage Immunity 35 2011 671 680
6. E.M. Shevach Biological functions of regulatory T cells Adv Immunol 112 2011 137 176
7. L. Li, and V.A. Boussiotis Molecular and functional heterogeneity of T regulatory cells Clin Immunol 141 2011 244 252
8. C.D. Dummer, V.N. Carpio, L.F. Gonçalves, R.C. Manfro, and F.V. Veronese FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance Transpl Immunol 26 2012 1 10
9. T. Yamaguchi, J.B. Wing, and S. Sakaguchi Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or non-inflammatory conditions Semin Immunol 23 2011 424 430
10. L. Vande Walle, T.D. Kanneganti, and M. Lamkanfi HMGB1 release by inflammasomes Virulence 2 2011 162 165
11. M.F. Tsan Heat shock proteins and high mobility group box 1 protein lack cytokine function J Leukoc Biol 89 2011 847 853
12. Y.M. Yao, Z.Y. Sheng, and L.F. Huang The effect of a novel cytokine, high mobility group box-1 protein, on the development of traumatic sepsis Chin J Integr Med 5 2009 13 15
13. W. Huang, Y. Tang, and L. Li HMGB1, a potent proinflammatory cytokine in sepsis Cytokine 51 2010 119 126
14. X.M. Zhu, F.H. Yao, Y.M. Yao, N. Dong, Y. Yu, and Z.Y. Sheng Endoplasmic reticulum stress and its regulator XBP-1 contributes to dendritic cell maturation and activation induced by high mobility group box-1 protein Int J Biochem Cell Biol 2012 10.1016/j.biocel.2012.03.018
15. Y. Zhang, Y.M. Yao, L.F. Huang, N. Dong, Y. Yu, and Z.Y. Sheng The potential effect and mechanism of high mobility group box 1 protein on regulatory T cell-mediated immunosuppression J Interferon Cytokine Res 31 2011 249 257
16. S.W. Kim, M.Z. Fan, and T.J. Applegate Nonruminant nutrition symposium on natural phytobiotics for health of young animals and poultry: mechanisms and application J Anim Sci 86 2008 E138 E139
17. W. Chen, Y.M. Li, and M.H. Yu Astragalus polysaccharides inhibited diabetic cardiomyopathy in hamsters depending on suppression of heart chymase activation J Diabetes Complications 24 2010 199 208
18. X.Q. Ma, Q. Shi, J.A. Duan, T.T. Dong, and K.W. Tsim Chemical analysis of Radix Astragali (Huangqi) in China: a comparison with its adulterants and seasonal variations J Agric Food Chem 50 2002 4861 4866
19. State Pharmacopoeia Commission of the PRC Pharmacopoeia of the People's Republic of China: V. 1 2005 People's Medical Publishing House Beijing
20. C. Tohda, T. Tamura, S. Matsuyama, and K. Komatsu Promotion of axonal maturation and prevention of memory loss in mice by extracts of Astragalus mongholicus Br J Pharmacol 149 2006 532 541
21. Y. Zhang, H. Zhu, C. Huang, X. Cui, Y. Gao, and Y. Huang Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma J Cardiovasc Pharmacol 47 2006 190 195
22. W.D. Zhang, H. Chen, C. Zhang, R.H. Liu, H.L. Li, and H.Z. Chen Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro Planta Med 72 2006 4 8
23. W.D. Zhang, C. Zhang, X.H. Wang, P.J. Gao, D.L. Zhu, and H. Chen Astragaloside IV dilates aortic vessels from normal and spontaneously hypertensive rats through endothelium-dependent and endothelium-independent ways Planta Med 72 2006 621 626
24. Q.C. Yu, T.Y. Zhu, and Y.K. Zhang Effect of astrgaloside IV on the long-term consequences of renal ischemia-reperfusion injury in rat Zhonghua Yi Xue Za Zhi 84 2004 1412 1415
25. Y. Luo, Z. Qin, Z. Hong, X. Zhang, D. Ding, and J.H. Fu Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia Neurosci Lett 363 2004 218 223
26. Q.Y. Liu, Y.M. Yao, Y. Yu, N. Dong, and Z.Y. Sheng Astragalus polysaccharides attenuate postburn sepsis via inhibiting negative immunoregulation of CD4+ CD25(high) T cells PLoS One 6 2011 e19811
27. J. Wilmanski, M. Siddiqi, E.A. Deitch, and Z. Spolarics Augmented IL-10 production and redox-dependent signaling pathways in glucose-6-phosphate dehydrogenase-deficient mouse peritoneal macrophages J Leukoc Biol 78 2005 85 94
28. M.P. MacConmara, A.A. Maung, and S. Fujimi Increased CD4+CD25+ T regulatory cell activity in trauma patients depresses protective Th1 immunity Ann Surg 244 2006 514 523
29. L.F. Huang, Y.M. Yao, N. Dong, Y. Yu, L.X. He, and Z.Y. Sheng Association between regulatory T cell activity and sepsis and outcome of severely burned patients:a prospective, observational study Crit Care 14 2010 R3
30. T.D. Zwar, S. Read, and I.R. van Driel CD4+CD25+ regulatory T cells inhibit the antigen-dependent expansion of self-reactive T cells in vivo J Immunol 176 2006 1609 1617
31. P. Lewkowicz, N. Lewkowicz, A. Sasiak, and H. Tchórzewski Lipopolysaccharide- activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death J Immunol 177 2006 7155 7163
32. N. Ralainirina, A. Poli, T. Michel, L. Poos, E. Andrès, and F. Hentges Control of NK cell functions by CD4+CD25+ regulatory T cells J Leukoc Biol 81 2007 144 153
33. J. Sunden-Cullberg, A. Norrby-Teglund, and C.J. Treutiger The role of high mobility group box-1 protein in severe sepsis Curr Opin Infect Dis 19 2006 231 236
34. L.F. Huang, Y.M. Yao, L.T. Zhang, N. Dong, Y. Yu, and Z.Y. Sheng The effect of high mobility group box-1 protein on activity of regulatory T cells after thermal injury in rats Shock 31 2009 322 329
35. L.F. Huang, Y.M. Yao, N. Dong, Y. Yu, L.X. He, and Z.Y. Sheng Association of high mobility group box-1 protein levels with sepsis and outcome of severely burned patients Cytokine 53 2011 29 34
36. Q. Li, A. Shakya, X. Guo, H. Zhang, D. Tantin, and P.E. Jensen Constitutive nuclear localization of NFAT in foxp3+ regulatory T cells independent of calcineurin activity J Immunol 188 2012 4268 4277
37. L.T. Krausz, E. Fischer-Fodor, Z.Z. Major, and B. Fetica GITR-expressing regulatory T-cell subsets are increased in tumor-positive lymph nodes from advanced breast cancer patients as compared to tumor-negative lymph nodes Int J Immunopathol Pharmacol 25 2012 59 66
38. L.E. van der Vlugt, L.A. Labuda, A. Ozir-Fazalalikhan, E. Lievers, A.K. Gloudemans, and K.Y. Liu Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells PLoS One 7 2012 e30883
39. W.J. Zhang, P. Hufnagl, B.R. Binder, and J. Wojta Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression Thromb Haemost 90 2003 904 914
40. Y.P. Wang, X.Y. Li, C.Q. Song, and Z.B. Hu Effect of astragaloside IV on T, B lymphocyte proliferation and peritoneal macrophage function in mice Acta Pharmacol Sin 23 2002 263 276
41. Y. Luo, Z. Qin, Z. Hong, X.D. Zhang, and J.H. Fu Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia Neurosci Lett 363 2004 218 223
42. Z. Ma, and Z. Yang Scavenging effects of Astragalus and Gynostemma pentaphyllum with its product on O2-. and.OH Zhong Yao Cai 22 1999 303 306
43. J.Y. Hu, J. Han, Z.G. Chu, H.P. Song, D.X. Zhang, and Q. Zhang Astragaloside IV attenuates hypoxia-induced cardiomyocyte damage in rats by upregulating superoxide dismutase-1 levels Clin Exp Pharmacol Physiol 36 2009 351 357
44. W.J. Zhang, P. Hufnagl, B.R. Binder, and J. Wojta Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappa B activation and adhesion molecule expression Thromb Haemost 90 2003 904 914
45. Q.Y. Liu, Y.M. Yao, S.W. Zhang, and Z.Y. Sheng Astragalus polysaccharides regulate T cell-mediated immunity via CD11c(high)CD45RB(low) DCs in vitro J Ethnopharmacol 136 2011 457 464